| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/02/2013 | CN102850321A Aroxylpyrimidine formamide or aroxylpyridine formamide compound and its preparation method, pharmaceutical composition, and application |
| 01/02/2013 | CN102850236A Novel benzamide histone deacetylase inhibitor and application thereof |
| 01/02/2013 | CN102358731B 2-substituted-6,7-dimethoxy tetralin isoquinoline derivative, preparation method thereof, medicinal composition and application thereof |
| 01/02/2013 | CN102250015B Penta-substituted tetrahydropyridine capable of carrying out aggregation-induced emission as well as preparation method and application thereof |
| 01/02/2013 | CN102190649B Method for preparing alpha-imatinib mesylate |
| 01/02/2013 | CN101973981B Refining method of 1-(5-isoquinoline sulfonyl) homopiperazine hydrochloride |
| 01/02/2013 | CN101830889B 嘧啶衍生物 Pyrimidine derivatives |
| 01/02/2013 | CN101747321B Indole-3-benzylamine derivative, preparation method and application |
| 01/02/2013 | CN101735200B Quinazoline compound |
| 01/02/2013 | CN101675036B Dual-acting benzoimidazole antihypertensive agents |
| 01/02/2013 | CN101595084B Biaryl compositions and methods for modulating a kinase cascade |
| 01/02/2013 | CN101547907B 抗菌的喹啉衍生物 Antibacterial quinoline derivatives |
| 01/02/2013 | CN101511816B An aminoisoquinoline thrombin inhibitor with improved bioavailability |
| 01/02/2013 | CN101511797B Benzimidazole modulators of VR1 |
| 01/02/2013 | CN101400654B 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
| 01/02/2013 | CN101277946B Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 01/02/2013 | CN101273016B 抗菌喹啉衍生物 Antibacterial quinoline derivatives |
| 01/02/2013 | CN101228149B Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 01/02/2013 | CN101189222B Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| 01/02/2013 | CN101087757B Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them |
| 01/02/2013 | CN101084195B 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/01/2013 | US8344160 Pyrrolone melanin concentrating hormone receptor-1 antagonists |
| 01/01/2013 | US8344150 Pyrrole end-capped bipyridine assay powder for selective detection of zinc ions and a process for the preparation thereof |
| 01/01/2013 | US8344138 Triazinedione derivatives as GABAB receptor modulators |
| 01/01/2013 | US8344137 3,3-dimethyl tetrahydroquinoline derivatives |
| 01/01/2013 | US8344010 Fused imidazole derivatives as TRPV3 antagonist |
| 01/01/2013 | US8344005 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoMethylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2 as NK1 receptor antagonists |
| 01/01/2013 | US8344003 2-pyridinecarboxamide derivatives |
| 01/01/2013 | US8344002 Compound having β-secretase inhibitory activity |
| 01/01/2013 | US8344000 Compounds which have activity at M1 receptor and their uses in medicine |
| 01/01/2013 | US8343989 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor |
| 01/01/2013 | US8343988 Inhibitors of histone deacetylase |
| 01/01/2013 | US8343987 Heterocyclic derivatives |
| 01/01/2013 | US8343982 Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same |
| 01/01/2013 | US8343980 Quinazoles useful as modulators of ion channels |
| 01/01/2013 | US8343966 Organic compounds |
| 01/01/2013 | US8343958 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists |
| 01/01/2013 | US8343952 Prolyl hydroxylase inhibitors and methods of use |
| 12/27/2012 | WO2012177896A1 Trpm8 antagonists and their use in treatments |
| 12/27/2012 | WO2012177844A2 Substituted imidazopyridinyl-aminopyridine compounds |
| 12/27/2012 | WO2012177728A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | WO2012177725A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | WO2012177678A2 Isotopologues of pomalidomide |
| 12/27/2012 | WO2012177638A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | WO2012177635A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | WO2012177608A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | WO2012177603A2 Metalloenzyme inhibitor compounds |
| 12/27/2012 | WO2012176856A2 Pesticide |
| 12/27/2012 | WO2012176763A1 Novel indazole derivative |
| 12/27/2012 | WO2012176140A1 Process for the preparation of dexlansoprazole |
| 12/27/2012 | WO2012176123A1 3 - imidazolyl- indoles for the treatment of proliferative diseases |
| 12/27/2012 | WO2012175581A1 Antiviral compounds |
| 12/27/2012 | WO2012175536A1 Dyes, method of making them, and their use in dye-sensitized solar cells |
| 12/27/2012 | WO2012175520A1 Hydroxy substituted isoquinolinone derivatives |
| 12/27/2012 | WO2012174856A1 Oral thrombin inhibitor and preparation method and medical use thereof |
| 12/27/2012 | WO2012150829A3 Noble triazolopyridine derivative or pharmaceutically acceptable salts thereof, production method thereof, and pharmaceutical composition including same |
| 12/27/2012 | WO2012136834A9 Pyrimidine derivatives for the treatment of viral infections |
| 12/27/2012 | WO2011115725A3 Indazole compounds as kinase activity modulators for the treatment of cancer and related disorders |
| 12/27/2012 | WO2011100838A9 Derivatives of l-plienyl-1.5-diliydio-benzo[b] [1.4]diazepine-2.4-dione as inhibitors of hiv replication |
| 12/27/2012 | US20120330019 Hepatitis C Virus Inhibitors |
| 12/27/2012 | US20120330014 Method for producing imatinib base |
| 12/27/2012 | US20120330009 Triazole compounds that modulate hsp90 activity |
| 12/27/2012 | US20120329830 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use |
| 12/27/2012 | US20120329820 Pyridinoylpiperidines As 5-HT1F Agonists |
| 12/27/2012 | US20120329810 Imatinib mesylate oral pharmaceutical composition and process for preparation thereof |
| 12/27/2012 | US20120329807 Multimeric VLA-4 Antagonists Comprising Polymers Moieties |
| 12/27/2012 | US20120329802 Metalloenzyme inhibitor compounds |
| 12/27/2012 | US20120329797 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents |
| 12/27/2012 | US20120329796 Compounds useful for treating premature aging and in particular progeria |
| 12/27/2012 | US20120329795 Quinazoline derivatives |
| 12/27/2012 | US20120329788 Metalloenzyme inhibitor compounds |
| 12/27/2012 | US20120329786 Compounds and therapeutic uses thereof |
| 12/27/2012 | US20120329785 Novel kinase inhibitors |
| 12/27/2012 | US20120329778 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 12/27/2012 | US20120329772 Amino-tetrazoles analogues and methods of use |
| 12/27/2012 | US20120329771 Benzylic oxindole pyrimidines |
| 12/27/2012 | US20120329743 Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators |
| 12/27/2012 | US20120328570 Hepatitis C Virus Inhibitors |
| 12/27/2012 | US20120328565 Antiviral compounds |
| 12/27/2012 | US20120326133 Novel compound and organic light-emitting device including the same |
| 12/27/2012 | US20120325200 Nano-Templated Energy Storage Materials |
| 12/27/2012 | CA2877474A1 Compounds and therapeutic uses thereof |
| 12/27/2012 | CA2840309A1 Process for the preparation of dexlansoprazole |
| 12/27/2012 | CA2839883A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | CA2839769A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | CA2839703A1 Trpm8 antagonists and their use in treatments |
| 12/27/2012 | CA2839699A1 Trpm8 antagonists and their use in treatments |
| 12/27/2012 | CA2839691A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | CA2838916A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | CA2838912A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | CA2838909A1 Metalloenzyme inhibitor compounds |
| 12/27/2012 | CA2837727A1 Substituted imidazopyridinyl-aminopyridine compounds |
| 12/26/2012 | EP2537843A2 Preparation of maleate salt of neratininb and its use |
| 12/26/2012 | EP2537830A1 Compounds and compositions as protein kinase inhibitors |
| 12/26/2012 | EP2536711A1 5-ht receptor modulators |
| 12/26/2012 | EP2536710A2 Piperidine derivatives |
| 12/26/2012 | EP2536709A2 Prolylhydroxylase inhibitors and methods of use |
| 12/26/2012 | EP2536708A2 Androgen receptor modulators and uses thereof |
| 12/26/2012 | EP2536707A1 Process for the preparation of alpha form of imatinib mesylate |
| 12/26/2012 | EP2536706A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same |